Stay updated on Immunotherapy+IRE in Pancreatic Adenocarcinoma Clinical Trial
Sign up to get notified when there's something new on the Immunotherapy+IRE in Pancreatic Adenocarcinoma Clinical Trial page.

Latest updates to the Immunotherapy+IRE in Pancreatic Adenocarcinoma Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedRevision: v3.5.0 was added and Revision: v3.4.3 was removed.SummaryDifference0.1%

- Check17 days agoChange DetectedAdded Revision: v3.4.3 and deleted Revision: v3.4.2.SummaryDifference0.1%

- Check24 days agoNo Change Detected
- Check45 days agoChange DetectedAdded Revision: v3.4.2 and removed the government-funding operating-status notice.SummaryDifference0.5%

- Check52 days agoChange DetectedA new system notice informs users about government funding lapse and the NIH Clinical Center's status. The revision history shows version v3.4.1, replacing v3.4.0.SummaryDifference0.5%

- Check59 days agoChange DetectedUI updates add a glossary display option and new metadata labels (Last Update Submitted that Met QC Criteria, Last Update Posted) along with a footer note (No FEAR Act Data) and a site revision indicator (v3.4.0), replacing the previous v3.3.4.SummaryDifference0.3%

- Check74 days agoChange DetectedThe page now shows Revision: v3.3.4, replacing Revision: v3.3.3.SummaryDifference0.1%

Stay in the know with updates to Immunotherapy+IRE in Pancreatic Adenocarcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Immunotherapy+IRE in Pancreatic Adenocarcinoma Clinical Trial page.